-
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al DC CAFC
- 2:15-cv-08180
- D.N.J.
- Judge: Stanley R. Chesler
+1
- Filed: 11/19/2015
- Closed: 12/28/2020
- Latest Docket Entry: 12/28/2020
- PACER
- Docket updated daily
4
Plaintiffs
4
Defendants
1
Accused
Product
5
Patents-in-Suit
1,867
Days in
Litigation
-
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al DC CAFC
- 2:15-cv-08180
- D.N.J.
- Judge: Stanley R. Chesler
+1
- Filed: 11/19/2015
- Closed: 12/28/2020
- Latest Docket Entry: 12/28/2020
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Mylan Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 12 mg/0.6 mL methylnaltrexone bromide formulation for subcutaneous injection | US 8,552,025 B2 |
8
|
Infringement
Entry 321
|
Mylan Laboratories Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 12 mg/0.6 mL methylnaltrexone bromide formulation for subcutaneous injection | US 8,552,025 B2 |
8
|
Infringement
Entry 321
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 12 mg/0.6 mL methylnaltrexone bromide formulation for subcutaneous injection | US 8,552,025 B2 |
8
|
Infringement
Entry 321
|
